CXCR4 and acute myeloid leukemia: The disruption of CXCR4/CXCL12 interaction blocks downstream signals such as PI3K/AKT and MAPK pathways, mediating AML cells mobilizing from their shelter to augment targeted delivery of chemotherapeutic agents.